Cargando…
Variable heavy–variable light domain and Fab-arm CrossMabs with charged residue exchanges to enforce correct light chain assembly
Technologies for the production of bispecific antibodies need to overcome two major challenges. The first one is correct heavy chain assembly, which was solved by knobs-into-holes technology or charge interactions in the CH3 domains. The second challenge is correct light chain assembly. This can be...
Autores principales: | Regula, Joerg Thomas, Imhof-Jung, Sabine, Mølhøj, Michael, Benz, Joerg, Ehler, Andreas, Bujotzek, Alexander, Schaefer, Wolfgang, Klein, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277175/ https://www.ncbi.nlm.nih.gov/pubmed/30169707 http://dx.doi.org/10.1093/protein/gzy021 |
Ejemplares similares
-
The use of CrossMAb technology for the generation of bi- and multispecific antibodies
por: Klein, Christian, et al.
Publicado: (2016) -
DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity
por: Sustmann, Claudio, et al.
Publicado: (2019) -
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
por: Regula, Jörg T, et al.
Publicado: (2016) -
Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins
por: Surowka, Marlena, et al.
Publicado: (2021) -
Crystal Structure of an Anti-Ang2 CrossFab Demonstrates Complete Structural and Functional Integrity of the Variable Domain
por: Fenn, Sebastian, et al.
Publicado: (2013)